HOPING 4 JUSTICE
Documents supporting record corrections
Fast facts supporting record corrections
- As early as 1985 the DoD knew there was: "no vaccine in current use which will safely and effectively protect military personnel against exposure to this hazardous bacterial agent.
- Notice of Intent to Revoke (NOIR) licensure issued by the FDA in 1997 due to deviations.
- In 1998 & 1999, the same time mandatory vaccinations by DoD began, the FDA determined the manufacturing process for anthrax vaccine was "not validated."
- Federal courts ruled the vaccine was "investigational" and illegal in 2003 and that the FDA never finalized the vaccine's license.
- Federal courts ordered a halt to the vaccine program for violating 10 USC §1107 due to use of an unlicensed & experimental vaccine.
- Congressional reports, SR 103-97 & HR 106-556, "Unproven Force Protection," questioned safety and efficacy of the vaccine, along with a multitude of GAO reports.
- DoD memos to the Secretary of Defense recommended minimizing use of the vaccine.
- White House Office memos expressed concerns about the anthrax vaccine prior to the 2001 anthrax letter attacks.
- Congressional efforts included legislation, HR 5166, for correction of military records for troops punished during the timeframes that the program was illegal.
- It was not until 2008 to 2010 that the FBI concluded the anthrax letter attacks against Sen. Daschle, etc., were committed by a US Army scientist whose motive was to save his "failing" anthrax vaccine program by creating a "scenario where people all of a sudden realize the need to have this vaccine."
- In the interim, despite the risks, DoD renewed vaccinations after FDA licensed the vaccine in 2005. DoD officials maintained: "The anthrax attacks in October 2001 illustrated the risk..."
- DoD referred cases to the FBI, but they were ignored.
- Emergent BioSolutions, the company that "ruined" millions of Johnson & Johnson COVID vaccines is the same company that produces the anthrax vaccine, previously named BioPort. Historic FDA Form 483 deviation reports are available below.